lonafarnib has been researched along with Viremia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bram, Y; Chiriboga, L; Cullen, J; Frankel, AS; Gerges, S; Giersch, K; Heller, B; Hrebikova, G; Huang, T; Johnson, H; Low, BE; Lutgehetmann, M; Nahass, RG; Pais, MA; Ploss, A; Schwartz, RE; Sellau, J; Seneca, K; Sharon, Y; Shirvani-Dastgerdi, E; Toettcher, JE; Wiles, MV; Winer, BY | 1 |
1 other study(ies) available for lonafarnib and Viremia
Article | Year |
---|---|
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
Topics: Adaptive Immunity; Animals; Disease Models, Animal; Drug Therapy, Combination; Genome, Viral; Glycoproteins; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Immunity, Innate; Immunocompetence; Lipopeptides; Mice, Inbred C57BL; Mice, Transgenic; Organic Anion Transporters, Sodium-Dependent; Piperidines; Pyridines; Symporters; Transgenes; Viremia | 2018 |